Dois-je éviter 4-methylbenzylidene camphor pendant la grossesse ? | VeriMom

What to use instead

Pregnancy-safe ingredients that serve a similar function:

FAQ

4-methylbenzylidene camphor est-il sûr pendant la grossesse ?

Authoritative EU committee work (SCCS / related opinions) reports that 4-methylbenzylidene camphor (4-MBC) exhibits endocrine‑disrupting activity (thyroid and estrogen systems) and that safety could not be confirmed because of data gaps (including genotoxicity uncertainties), supporting a 'suspected' reproductive hazard. Dermal kinetic studies in humans show measurable systemic absorption/metabolites after topical application, and multiple studies report detection of 4-MBC or metabolites in human tissues/fluids, supporting moderate exposure from cosmetics. Sources: SCCS opinion (EU/European Commission), human dermal kinetics and biomonitoring studies.

4-methylbenzylidene camphor est-il sûr pendant l'allaitement ?

4-MBC has been measured in human breast milk and breast tissue in several studies, demonstrating maternal body burden and a plausible exposure route to nursing infants; combined with demonstrated endocrine activity in in vivo and in vitro studies, this supports a 'suspected' hazard and demonstrated mechanism. Measured systemic levels after dermal use indicate moderate likelihood of transfer to milk. Sources: biomonitoring and kinetics studies, SCCS discussion.

4-methylbenzylidene camphor est-il sûr pour la peau de bébé ?

Hazard and mechanism scores are the same as for adults because evidence of endocrine activity and reproductive/developmental effects comes from animal and mechanistic studies (SCCS and peer‑reviewed literature). Because 4-MBC is lipophilic, dermally absorbable and has measurable systemic uptake in adults, infant skin exposure should be considered higher: per the requested framework, increase exposure by +1 for 0–3 yr (adult e=2 → infant e=3). Additionally, 4-MBC has been shown to bioaccumulate and to produce endocrine effects in developing models (fish/rodent), increasing concern for infants.

Comment VeriMom évalue-t-il 4-methylbenzylidene camphor ?

VeriMom évalue 4-methylbenzylidene camphor à 13/100 (risque élevé) sur la base du statut EU CosIng, des classifications ECHA et des études PubMed.

Quelles sont les alternatives sûres à 4-methylbenzylidene camphor pendant la grossesse ?

Consultez notre liste d'alternatives sûres à 4-methylbenzylidene camphor basée sur une fonction similaire et une classification sans risques connus.